Global Prenatal Testing and New-born Screening Market, By Type (New-born Screening, Prenatal Testing), Test (Non-Invasive, Invasive), Product (Ultrasonography, Tandem Quadrupole Detector, Reagent and Assay Kits, Hearing Screen Instruments, Incubator Shaker), Technology (Screening Technology, Diagnostic Technology, Mass Spectrometry, Enzyme Immunoassays, Electrophoresis, DNA Assays), End User (Hospitals, Diagnostic Centres, Maternity and Specialty Clinics), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Prenatal Testing and New-born Screening Market
The prenatal testing and new-born screening market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account from USD 4889.03 million in 2020 to USD 10541.25 million by 2028 growing at a CAGR of 10.08% in the above-mentioned forecast period.
The prenatal testing and new-born screening tests basically includes series of tests conducted during pregnancy or during the early days of the babies to determine various genetic and chromosomal diseases or diseases such as sickle cell, down’s syndrome, cystic fibrosis, birth defects, gene mutations, cystic fibrosis and muscular dystrophy to provide timely medical or surgical treatment of a condition before or after birth. They are used to determine the health of the fetus at an early stage or during early days of babies for detection of certain disorders or health issues which might hinder their growth and development.
The high prevalence of genetic diseases such as sickle cell anaemia, down syndrome, cystic fibrosis and muscular dystrophy in infants is estimated to accelerate the growth of the market as these diseases are detected by these tests. The favourable governmental regulations and standards and the non-invasive testing are also anticipated to drive the market’s growth. However, the low healthcare access in remote areas can restrain the growth of the market. The introduction of more adaptable and focused tests and effective diagnosis are estimated to generate new lucrative opportunities for market within the forecast period. On the other hand, low awareness regarding the prenatal testing and new-born screening might prove as a major challenge for the growth of market.
This prenatal testing and new-born screening market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research prenatal testing and new-born screening market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Prenatal Testing and New-born Screening Market Scope and Market Size
Prenatal testing and new-born screening market is segmented on the basis of type, test, product, technology and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the prenatal testing and new-born screening market is segmented into new-born screening and prenatal testing.
- On the basis of test, the prenatal testing and new-born screening market is bifurcated into non-invasive and invasive.
- On the basis of product, the prenatal testing and new-born screening market is segmented into ultrasonography, tandem quadrupole detector, reagent and assay kits, hearing screen instruments and incubator shaker.
- On the basis of technology, the prenatal testing and new-born screening market is segmented into screening technology, diagnostic technology, mass spectrometry, enzyme immunoassays, electrophoresis and DNA assays.
- On the basis of end user, the prenatal testing and new-born screening market is segmented into hospitals, diagnostic centres, maternity centres and specialty clinics.
Prenatal Testing and New-born Screening Market Country Level Analysis
Prenatal testing and new-born screening market is analysed and market size insights and trends are provided by type, test, product, technology and end user as referenced above.
The countries covered in the prenatal testing and new-born screening market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.
North America is the most dominating region in the market due to the availability of well-established healthcare infrastructure coupled with advancements in whole-genome sequencing technologies within the region. On the other hand, Asia-Pacific region is anticipated to show at the most lucrative growth rate within the forecast period due to growing research and development activities and advancement in the next-generation sequencing (NGS) technologies especially in China.
The country section of the prenatal testing and new-born screening market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
prenatal testing and new-born screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for prenatal testing and new-born screening market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the prenatal testing and new-born screening market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Global Prenatal Testing and New-born Screening Market Share Analysis
Prenatal testing and new-born screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to prenatal testing and new-born screening market.
The major players covered in the prenatal testing and new-born screening market report are CRISPR Therapeutics, Abbott, Color Health, Inc., Bio-Rad Laboratories, Inc, QIAGEN, Agilent Technologies Inc, Editas Medicine, Illumina, Inc, Eurofins Scientific , Ravgen, PerkinElmer Inc, Progenity Inc, Laboratory Corporation of America Holdings, Natera, Inc., Cradle Genomics, F. Hoffmann-La Roche Ltd, Quest Diagnostics, Eurofins Scientific, Strand Life Sciences Pvt. Ltd., among other domestic players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-